Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2026)

Crinetics Pharmaceuticals' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.01 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 2529.91% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (up 2529.91% YoY), while the FY2025 annual figure was 0.01, up 498.72% from the prior year.
• Asset Utilization Ratio was 0.01 for Q1 2026 at Crinetics Pharmaceuticals, up from 0.01 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2023 to a low of 0.0 in Q1 2025.
• Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2025.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio soared 3900.67% in 2022, then tumbled 90.91% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then slumped by 51.1% to 0.01 in 2023, then slumped by 86.06% to 0.0 in 2024, then jumped by 656.56% to 0.01 in 2025, then surged by 115.71% to 0.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.